WCG Clinical, Inc. (WCGC)

WCG Clinical was planning to go public, but the IPO has been withdrawn.
IPO Price Range
$15.00 - $17.00
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 6.05B
Revenue (ttm) 497.58M
Net Income (ttm) -85.81M
Shares Out 378.26M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About WCGC

WCG Clinical is a leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. Our transformational solutions enable biopharmaceutical companies, contract research organizations (“CROs”), and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection. Our proprietary suite of technology-enabled solutions provides ... [Read more...]

Industry Biological Research
Founded 2012
CEO Donald A. Deieso, Ph.D.
Employees 1,322
Stock Exchange NASDAQ
Ticker Symbol WCGC
Full Company Profile

Financial Performance

Financial Statements


WCG Clinical IPO Registration Document (S-1)

WCG Clinical Inc, a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering (IPO) in the United States on Thursday and revealed a jump...

1 year ago - Reuters

WCG Clinical IPO Registration Document (S-1)

WCG Clinical, Inc. has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC